Personalized medicine: hype or reality.
Bruce A Chabner, Leif W Ellisen, A John Iafrate
No abstract text available.
- Lancet. 2010 Aug 28;376(9742):687-97
[PMID: 20728210]
- Blood. 2008 Dec 15;112(13):4808-17
[PMID: 19064740]
- Oncologist. 2012;17(11):1351-75
[PMID: 22989574]
- N Engl J Med. 2010 Jun 24;362(25):2380-8
[PMID: 20573926]
- Nat Rev Clin Oncol. 2012 Apr 03;9(6):359-66
[PMID: 22473105]
- N Engl J Med. 2013 Jun 20;368(25):2385-94
[PMID: 23724913]
- N Engl J Med. 2001 Mar 15;344(11):783-92
[PMID: 11248153]
- N Engl J Med. 2004 May 20;350(21):2129-39
[PMID: 15118073]
- N Engl J Med. 2010 Aug 26;363(9):809-19
[PMID: 20818844]
- Clin Cancer Res. 2008 Dec 1;14(23):7726-32
[PMID: 19047099]
- J Clin Oncol. 2012 Mar 10;30(8):863-70
[PMID: 22215748]
- N Engl J Med. 2012 Nov 29;367(22):2075-88
[PMID: 23190221]
- BMC Cancer. 2013 Feb 02;13:49
[PMID: 23374602]
- J Mol Diagn. 2011 Jan;13(1):64-73
[PMID: 21227396]
- N Engl J Med. 2002 Aug 15;347(7):472-80
[PMID: 12181401]
- N Engl J Med. 2010 Oct 28;363(18):1693-703
[PMID: 20979469]
Humans
Pharmacogenetics
Precision Medicine